1-2 of 2
Ichiro Nagata
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutational Analysis of BRCA1 and BRCA2 and Clinicopathologic Analysis of Ovarian Cancer in 82 Ovarian Cancer Families: Two Common Founder Mutations of BRCA1 in Japanese Population

Masayuki Sekine, Hiroshi Nagata, Shoji Tsuji, Yasuo Hirai, Seiichiro Fujimoto, Masayuki Hatae, Iwao Kobayashi, Tsuneo Fujii, Ichiro Nagata, Kimio Ushijima, Koshiro Obata, Mitsuaki Suzuki, Mitsuhiro Yoshinaga, Naohiko Umesaki, Shinji Satoh, Takayuki Enomoto, Satoru Motoyama, Kenichi Tanaka, The Japanese Familial Ovarian Cancer Study Group
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (10): 3144–3150.
Published: 01 October 2001
View article titled, Mutational Analysis of <em>BRCA1</em> and <em>BRCA2</em> and Clinicopathologic Analysis of Ovarian Cancer in 82 Ovarian Cancer Families: <subtitle>Two Common Founder Mutations of <em>BRCA1</em> in Japanese Population</subtitle>
Open the PDF for Mutational Analysis of <em>BRCA1</em> and <em>BRCA2</em> and Clinicopathologic Analysis of Ovarian Cancer in 82 Ovarian Cancer Families: <subtitle>Two Common Founder Mutations of <em>BRCA1</em> in Japanese Population</subtitle> in another window
Journal Articles

Gains of 1q21–q22 and 13q12–q14 Are Potential Indicators for Resistance to Cisplatin-based Chemotherapy in Ovarian Cancer Patients

Kazuya Kudoh, Masashi Takano, Tomoyuki Koshikawa, Misako Hirai, Sadao Yoshida, Yoshinori Mano, Kenji Yamamoto, Kenji Ishii, Tsunekazu Kita, Yoshihiro Kikuchi, Ichiro Nagata, Masanao Miwa, Kazuhiko Uchida
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2526–2531.
Published: 01 September 1999
View article titled, Gains of 1q21–q22 and 13q12–q14 Are Potential Indicators for Resistance to Cisplatin-based Chemotherapy in Ovarian Cancer Patients
Open the PDF for Gains of 1q21–q22 and 13q12–q14 Are Potential Indicators for Resistance to Cisplatin-based Chemotherapy in Ovarian Cancer Patients in another window